Search Results - "Naruoka, Haruna"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Therapeutic Effects of MicroRNA-582-5p and -3p on the Inhibition of Bladder Cancer Progression by Uchino, Keita, Takeshita, Fumitaka, Takahashi, Ryou-u, Kosaka, Nobuyoshi, Fujiwara, Kae, Naruoka, Haruna, Sonoke, Satoru, Yano, Junichi, Sasaki, Hideo, Nozawa, Shiari, Yoshiike, Miki, Kitajima, Kazuki, Chikaraishi, Tatsuya, Ochiya, Takahiro

    Published in Molecular therapy (01-03-2013)
    “…Many reports have indicated that the abnormal expression of microRNAs (miRNAs) is associated with the progression of disease and have identified miRNAs as…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Analyses of mitogen-activated protein kinase function in the maturation of porcine oocytes by Ohashi, S, Naito, K, Sugiura, K, Iwamori, N, Goto, S, Naruoka, H, Tojo, H

    Published in Biology of reproduction (01-02-2003)
    “…The function of mitogen-activated protein kinase (MAPK) during porcine oocyte maturation was examined by injecting oocytes with either mRNA or antisense RNA of…”
    Get full text
    Journal Article
  4. 4

    Effects of spindle removal on MPF and MAP kinase activities in porcine matured oocytes by Goto, Seitaro, Naito, Kunihiko, Ohashi, Satoshi, Sugiura, Koji, Naruoka, Haruna, Iwamori, Naoki, Tojo, Hideaki

    Published in Molecular reproduction and development (01-11-2002)
    “…Intracellular localization of maturation/M‐phase promoting factor (MPF) and mitogen activated protein (MAP) kinase in mature oocytes has been examined by…”
    Get full text
    Journal Article
  5. 5

    Antiproliferative and Antitumor Effects of Azacitidine Against the Human Myelodysplastic Syndrome Cell Line SKM-1 by KIMURA, Sachie, KURAMOTO, Kazuya, HOMAN, Junko, NARUOKA, Haruna, EGO, Takeshi, NOGAWA, Masaki, SUGAHARA, Seishi, NAITO, Haruna

    Published in Anticancer research (01-03-2012)
    “…The myelodysplastic syndromes (MDS) are a group of stem cell disorders characterized by dysplasia of one or more hematopoietic cell lineages and a risk of…”
    Get full text
    Journal Article
  6. 6

    Synthesis, gene-silencing activity and nuclease resistance of 3′–3′-linked double short hairpin RNA by Masuda, Hirofumi, Watanabe, Naoki, Naruoka, Haruna, Nagata, Seigo, Takagaki, Kazuchika, Wada, Takeshi, Yano, Junichi

    Published in Bioorganic & medicinal chemistry (01-12-2010)
    “…Short hairpin RNAs linked at their 3′ ends by glycerol show structure-dependent gene-silencing activity as well as higher exonuclease resistance and lower…”
    Get full text
    Journal Article
  7. 7

    In vivo antiproliferative effect of NS-187, a dual Bcr-Abl/Lyn tyrosine kinase inhibitor, on leukemic cells harbouring Abl kinase domain mutations by Naito, Haruna, Kimura, Shinya, Nakaya, Yohei, Naruoka, Haruna, Kimura, Sachie, Ito, Shinsaku, Wakayama, Tatsushi, Maekawa, Taira, Hirabayashi, Kazuko

    Published in Leukemia research (01-11-2006)
    “…Advanced-phase chronic myeloid leukemia patients treated with imatinib often relapse due to point mutations in the Abl kinase domain. We herein examine the in…”
    Get full text
    Journal Article
  8. 8

    Simultaneous Targeting of Lyn and Bcr-Abl Kinases by NS-187 Cures Mice Bearing Imatinib-Resistant Leukemic Cells by Naito, Haruna, Kimura, Shinya, Nakaya, Yohei, Naruoka, Haruna, Wakayama, Tatsushi, Kimura, Sachie, Ito, Shinsaku, Ashihara, Eishi, Maekawa, Taira, Hirabayashi, Kazuko

    Published in Blood (16-11-2005)
    “…We have identified a specific dual Bcr-Abl/Lyn inhibitor, NS-187 (elsewhere described as CNS-9), which is 25–55 times more potent than imatinib against wild…”
    Get full text
    Journal Article
  9. 9

    A Dual Bcr-Abl/Lyn Tyrosine Kinase Inhibitor, NS-187, Is a Novel Agent for Imatinib-Resistant Leukemia by Kimura, Shinya, Naito, Haruna, Yokota, Asumi, Kamitsuji, Yuri, Kawata, Eri, Ashihara, Eishi, Nakaya, Yohei, Naruoka, Haruna, Wakayama, Tatsushi, Asaki, Tetsuo, Niwa, Tomoko, Hirabayashi, Kazuko, Maekawa, Taira

    Published in Blood (16-11-2005)
    “…Chemical modifications of imatinib mesylate made with the guidance of molecular modeling yielded several promising compounds. Among them, we selected a…”
    Get full text
    Journal Article
  10. 10

    Analyses of Mitogen-Activated Protein Kinase Function in the Maturation of Porcine Oocytes1 by Ohashi, Satoshi, Naito, Kunihiko, Sugiura, Koji, Iwamori, Naoki, Goto, Seitaro, Naruoka, Haruna, Tojo, Hideaki

    Published in Biology of reproduction (01-02-2003)
    “…The function of mitogen-activated protein kinase (MAPK) during porcine oocyte maturation was examined by injecting oocytes with either mRNA or antisense RNA of…”
    Get full text
    Journal Article